NO941285D0 - Hemostatic mixture for local hemostasis - Google Patents

Hemostatic mixture for local hemostasis

Info

Publication number
NO941285D0
NO941285D0 NO941285A NO941285A NO941285D0 NO 941285 D0 NO941285 D0 NO 941285D0 NO 941285 A NO941285 A NO 941285A NO 941285 A NO941285 A NO 941285A NO 941285 D0 NO941285 D0 NO 941285D0
Authority
NO
Norway
Prior art keywords
local hemostasis
hemostatic mixture
hemostatic
mixture
hemostasis
Prior art date
Application number
NO941285A
Other languages
Norwegian (no)
Other versions
NO941285L (en
Inventor
Ulla Karin Elisabeth Hedner
Erik Hoegsbro Oestergaard
Martin William Edwards
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO941285D0 publication Critical patent/NO941285D0/en
Publication of NO941285L publication Critical patent/NO941285L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO941285A 1991-10-11 1994-04-08 Hemostatic mixture for local hemostasis NO941285L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77566491A 1991-10-11 1991-10-11
PCT/DK1992/000296 WO1993006855A1 (en) 1991-10-11 1992-10-09 Hemostatic composition for local hemostasis

Publications (2)

Publication Number Publication Date
NO941285D0 true NO941285D0 (en) 1994-04-08
NO941285L NO941285L (en) 1994-06-07

Family

ID=25105103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941285A NO941285L (en) 1991-10-11 1994-04-08 Hemostatic mixture for local hemostasis

Country Status (9)

Country Link
EP (1) EP0613377A1 (en)
JP (1) JPH07500095A (en)
AU (1) AU2793292A (en)
CA (1) CA2121028A1 (en)
CZ (1) CZ83194A3 (en)
FI (1) FI941628A (en)
HU (1) HUT67693A (en)
NO (1) NO941285L (en)
WO (1) WO1993006855A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273035T1 (en) * 1993-11-03 2004-08-15 Clarion Pharmaceuticals Inc HEMOSTATIC PLASTER
DE19903693A1 (en) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease for activation of coagulation factor VII
FR2754183A1 (en) * 1996-10-08 1998-04-10 Lefebvre Jean Marie VISCOUS HEMOSTATIC COMPOSITION, IN PARTICULAR IN THE CONDITION OF FROST
DE19710190A1 (en) * 1997-03-12 1998-09-17 Immuno Ag Activated vitamin K-dependent blood factor and method for its production
WO1998058661A1 (en) * 1997-06-23 1998-12-30 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
EP1200116B1 (en) * 1999-07-14 2008-10-15 Novo Nordisk Health Care AG USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
GB0011053D0 (en) 2000-05-09 2000-06-28 Hudson John O Medical device and use thereof
DK1282438T3 (en) * 2000-05-10 2005-11-14 Novo Nordisk Healthcare Ag Pharmaceutical composition comprising a factor VIIa and a factor XIII
US7015194B2 (en) 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
ATE316387T1 (en) 2000-09-22 2006-02-15 Perlei Medical Produkte Gmbh USE OF ANTIFIBRINOLYTICS FOR THE PREPARATION AND MANUFACTURING OF SWABS, COMPRESSES OR PLASTERS
EP1446147A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
WO2003039582A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid
WO2003039590A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides
JP2005510513A (en) 2001-11-09 2005-04-21 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Pharmaceutical compositions comprising factor VII polypeptide and TAFI polypeptide
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
US7078479B2 (en) 2001-11-09 2006-07-18 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
FR2894831B1 (en) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement THROMBIN FREE BIOLOGICAL GLUE AND USE THEREOF AS MEDICAMENT.
US8461115B2 (en) 2006-03-16 2013-06-11 Stellaris Pharmaceuticals Aps Methods for local treatment with factor VII
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
CA2717571C (en) 2008-03-03 2016-08-23 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
RU2501556C2 (en) * 2011-10-06 2013-12-20 Владимир Лазаревич Адамян Heamostatic match
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
BR112015030612B1 (en) 2013-06-21 2020-07-21 Ferrosan Medical Devices A/S method for preparing a dry composition
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (en) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Syringe for holding and mixing first and second substances
CN107771093B (en) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 Syringe for mixing two components and for maintaining vacuum under storage conditions
MX2018002649A (en) * 2015-09-01 2018-06-20 Baxter Int Hemostatic material.
ES2968412T3 (en) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Method for preparing a hemostatic composition
CN115605234B (en) * 2019-12-25 2024-08-27 广州倍绣生物技术有限公司 Hemostatic paste and use thereof
WO2024042148A1 (en) 2022-08-26 2024-02-29 Stellaris Pharmaceuticals Aps Haemorrhage inhibiting compositions and methods involving the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
ES2037664T3 (en) * 1985-11-26 1993-07-01 Novo Nordisk A/S COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMORRHAGIC DISORDERS.

Also Published As

Publication number Publication date
FI941628A0 (en) 1994-04-08
FI941628A (en) 1994-06-08
CZ83194A3 (en) 1994-11-16
CA2121028A1 (en) 1993-04-15
EP0613377A1 (en) 1994-09-07
WO1993006855A1 (en) 1993-04-15
AU2793292A (en) 1993-05-03
JPH07500095A (en) 1995-01-05
NO941285L (en) 1994-06-07
HUT67693A (en) 1995-04-28
HU9401008D0 (en) 1994-07-28

Similar Documents

Publication Publication Date Title
NO941285D0 (en) Hemostatic mixture for local hemostasis
BR9002402A (en) HEMOSTATIC CLAMP
AU570748B2 (en) Glass-filled absorbable surgical devices
DK44389A (en) SYNERGIC ANTIOXIDANT MIXTURE
BR8402644A (en) HEMOSTATIC CLAMP
DK333789A (en) TROCAR
NO961588D0 (en) New mixture
DE69031005D1 (en) Form manager
DK579389D0 (en) hemostasis valve
FR2648644B1 (en) MICROWAVE ANSWERER
FI962618A (en) Percutaneously absorbable preparation
DE3473820D1 (en) TROCAR
KR890017202U (en) Disposable tape for hemostasis
DE69221277D1 (en) High frequency mixer
DK33392A (en) UNIFORM MIXTURE
FI901250A0 (en) Stabilized synthetic mass-cellulose mixture
NO952987D0 (en) Wound healing mixture
NO922626D0 (en) PROCEDURE FOR THE PREPARATION OF LYSOZYM DIMERS
NO931839D0 (en) PROCEDURE FOR PERGOLID PREPARATION
DK72592D0 (en) TROCAR
NO893531L (en) MIXTURE FOR MIXTURES.
LV5014A3 (en) Bitumen-polymer composition
DK434589D0 (en) SYNERGISTIC MIXING
NO924397D0 (en) PROCEDURE FOR PRILLING
NO844829L (en) SYNERGIC HERBICID MIXTURE